🔗 Permalink

Inventor profile of:

Gary R. OSTROFF

City:

Worcester, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-05-22

Top Assignees for applications by Gary R. OSTROFF

The entities that hold a legal rights for patent applications filed by inventor OSTROFF Gary R.:

UNIVERSITY OF MASSACHUSETTS 14 Boston, MA United States
Biopolymer Engineering, Inc. 4 Eagan, MN United States
UNIVERSITY OF MASSACHUSETTS 2 Westborough, MA United States
Biothera, Inc. 2 Eagan, MN United States
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. 2 Louisville, KY United States
Biopolymer Engineering 1 Eagan, MN United States
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION 1 Louisville, KY United States
Biopolymer Engineering (d/b/a Biothera) 1 Eagan, MN United States

Recent patent applications by OSTROFF Gary R.

Gary R. OSTROFF from Worcester, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-22

US20250161373A1

Human necessities

PURIFIED ANTHELMINTIC COMPOSITIONS AND RELATED METHODS

#2 | 2024-10-24

US20240350419A1

Human necessities

ORAL ROOM-TEMPERATURE STABLE YEAST PARTICLES (YP) AND METHODS OF USE

#3 | 2024-05-09

US20240148800A1

Human necessities

Purified anthelmintic compositions and related methods

#4 | 2024-02-22

US20240058403A1

Human necessities

YEAST PARTICLES FOR DELIVERY OF WATER-ACTIVATED SELF-EMULSIFYING CANNABINOID FORMULATIONS

#5 | 2024-02-22

US20240058275A1

Human necessities

NANO-SILICA - IN YEAST PARTICLE (YP) DRUG ENCAPSULATION APPROACH FOR IMPROVED THERMAL AND HYDROLASE STABILITY OF YP DRUG DELIVERY FORMULATIONS

#6 | 2023-12-28

US20230413823A1

Human necessities

HYPERLOADED YEAST CELL WALL PARTICLE AND USES THEREOF

#7 | 2023-04-27

US20230128953A1

Human necessities

ANTHELMINTIC COMPOSITIONS AND METHODS

#8 | 2022-11-10

US20220354905A1

Human necessities

Purified anthelmintic compositions and related methods

#9 | 2021-01-28

US20210023017A1

Human necessities

YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS

#10 | 2020-06-18

US20200188452A1

Human necessities

Purified anthelmintic compositions and related methods

#11 | 2019-01-17

US20190015474A1

Human necessities

Anthelmintic compositions and methods

#12 | 2017-11-16

US20170326071A1

Human necessities

YEAST CELL WALL PARTICLES FOR RECEPTOR-TARGETED NANOPARTICLE DELIVERY

#13 | 2016-06-23

US20160175251A1

Human necessities

Yeast cell wall particles for receptor-targeted nanoparticle delivery

#14 | 2014-11-27

US20140350066A1

Human necessities

COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS

#15 | 2014-11-13

US20140335047A1

Human necessities

Drug delivery product and methods

#16 | 2013-03-14

US20130065941A1

Human necessities

COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS

#17 | 2012-03-22

US20120070376A1

Human necessities

Yeast cell wall particles for receptor-targeted nanoparticle delivery

#18 | 2012-02-16

US20120039929A1

Human necessities

Therapy for lysosomal enzyme deficiencies

#19 | 2011-02-10

US20110033475A1

Human necessities

Use of beta-glucans against biological warfare weapons and pathogens including anthrax

#20 | 2010-09-02

US20100221357A1

Human necessities

Drug delivery product and methods

#21 | 2010-08-31

US10268201

Use of beta-glucans against biological warfare weapons and pathogens including anthrax

#22 | 2010-07-01

US20100166751A1

Human necessities

CANCER THERAPY USING WHOLE GLUCAN PARTICLES AND ANTIBODIES

#23 | 2009-09-10

US20090226528A1

Human necessities

Encapsulated nanoparticles for nucleic acid delivery

#24 | 2009-08-20

US20090209624A1

Human necessities

COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS

#25 | 2009-06-25

US20090163439A1

Human necessities

Methods of using beta glucan as a radioprotective agent

#26 | 2008-02-21

US20080044438A1

Chemistry; metallurgy

Yeast Cell Particles As Oral Delivery Vehicles For Antigens

#27 | 2006-11-02

US20060247205A1

Human necessities

Very high molecular weight β-glucans

#28 | 2006-07-27

US20060165700A1

Human necessities

Cancer therapy using whole glucan particles and antibodies

#29 | 2006-04-20

US20060083718A1

Human necessities

Therapy for lysosomal enzyme deficiencies

#30 | 2006-04-04

US10094686

Very high molecular weight β-glucans

#31 | 2005-12-22

US20050281781A1

Human necessities

Drug delivery product and methods

#32 | 2005-11-03

US20050245480A1

Human necessities

Methods of using beta glucan as a radioprotective agent

InventorID:

141210 ⎘